Lesaffre Launches IBS Probiotic
Lesaffre Human Care (Milwaukee) has launched Lynside Pro GI+, a yeast-derived probiotic for intestinal discomfort.
Lesaffre Human Care (Milwaukee) has launched Lynside Pro GI+, a yeast-derived probiotic for intestinal discomfort.
The company states that its ingredient, derived from Saccharomyces cerevisiae yeast, can withstand the gastrointestinal tract and provide anti-inflammatory support in the face of intestinal pain, including that caused by Irritable Bowel Syndrome (IBS).
In a clinical trial conducted on the probiotic, 200 subjects with IBS symptoms were assigned to 500 mg Lynside Pro GI+ or placebo for eight weeks. After four weeks, treatment reduced intestinal pain and discomfort significantly compared to placebo.
The ingredient has been registered with the French National Collection of Microorganism Cultures, according to the company.
For more information, visit Lessafre Human Care.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.
New review paper highlights gut-brain benefits of novel herbal blend, Digexin
September 16th 2024NXT USA has announced the publication of a narrative review that offers an in-depth analysis of the efficacy and safety of its Digexin ingredient, which is a novel blend of Ashwagandha and okra extracts.
